The product page itself avoids therapeutic claims, dosing recommendations for human use, and any consumer-health positioning that would conflict with Canadian regulatory expectations
Dispensed responsibly , with boundaries such as limiting use to short courses (no more than 90 days) for acute injury recovery until more research is available
The first category, growth-hormone secretagogues such as CJC-1295 and Ipamorelin, is proposed to stimulate the pituitary gland's own growth-hormone release and downstream IGF-1 output, an approach tied to lean mass and recovery support in the research reviewed for this list
No prior numbing is required
Is cagrilintide a calcitonin receptor agonist
This results in faster collagen remodeling, improved elasticity, and stronger rejuvenation effects